# Descartes-08 in Autoantibody Myositis

> **NCT07391605** · PHASE2 · RECRUITING · sponsor: **Cartesian Therapeutics** · enrollment: 60 (estimated)

## Conditions studied

- Antisynthetase Syndrome

## Interventions

- **DRUG:** Descartes-08
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07391605
- **Lead sponsor:** Cartesian Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-28
- **Primary completion:** 2027-11
- **Final completion:** 2028-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07391605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07391605, "Descartes-08 in Autoantibody Myositis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07391605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*